Oct
16
GSK rubbishes media review claims
Posted in: UncategorizedLONDON – GlaxoSmithKline’s European media director Andy Bolden has flatly denied that the pharmaceutical and consumer healthcare giant is reviewing its £300m global media account.
Post a Comment